A company named Wyss, in collaboration with Heinz, has developed a product inspired by enzymes found in plants that appears to make sugar healthier. So far, according to the company, it is being tested in mice, not actual humans
Semaglutide functions as a synthetic version of GLP-1, binding to receptors in both the brain and gastrointestinal tract
These include reduction of systolic and diastolic blood pressure, body weight, vascular inflammation, and improvement of endothelial function [55,56,57,58]
Compound Stability Evaluation: Assessment of handling, preparation, and storage behavior under research conditions